Onsite Tobacco Cessation Treatment for Patients With PAD

University of Oklahoma (OU)

Status: Active, not recruiting

Conditions: Peripheral Artery Disease; Tobacco Cessation

Treatments: Behavioral: Tobacco Treatment Research Program Standard Care

Study type: Interventional

Funder types: Other

Identifiers

NCT05469698

12774

Details and patient eligibility

About

Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Participants will receive nicotine replacement therapy, counseling, and and complete questionnaires. We hypothesize that integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) can improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.

Enrollment: 15 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Have diagnosed peripheral artery disease
• Tobacco user
• 18 years of age or older
• Willing/able to attend all study visits
• Be able to read, speak, and understand English

Exclusion criteria

• Do not meet the specified inclusion criteria above

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Standard Care

Other group

Description:

All participants will receive standard care by the Tobacco Treatment Research Program. This includes nicotine replacement therapy such as patches, gum, or lozenges, counseling by a Tobacco Treatment Specialist, and complete questionnaires.

Treatment:

Behavioral: Tobacco Treatment Research Program Standard Care